Additionally, lower SETD7 expression predicted better OS in patients with low expression of the Nrf-2 target genes, which suggests that SETD7 protects BC cells from oxidative stress through downregulation of KEAP1 [44]. This evidence concerns the gene NFE2L2 and breast cancer.